Who
Kevin Raymond Merrill Smith
CEO and President
Company insider
Files Form 4 as: CEO and President, Inogen; Director, Oncosec Medical.
In numbers
- Trades disclosed
- 41
- Buys
- 1
- Sells
- 0
- Bought
- $100K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 29 May 2020
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | INGN InogenMedical Devices | SEC FORM 4 Code A | $7,9951,500 at $5.33 | filing |
| 1 Sep 2026filed 3 Sep 2026 | INGN InogenMedical Devices | SEC FORM 4 Code A | $7,9951,500 at $5.33 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code A | $4,179685 at $6.10 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN Inogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —30,012 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code A | —32,725 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code F | $100K16,374 at $6.10 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN Inogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —28,334 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN Inogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —30,012 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code M | —28,334 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code F | $84K13,700 at $6.10 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code M | —30,012 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code F | $89K14,511 at $6.10 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code A | $4,179685 at $6.10 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code A | —32,725 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code F | $100K16,374 at $6.10 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code M | —28,334 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code F | $84K13,700 at $6.10 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code M | —30,012 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN InogenMedical Devices | SEC FORM 4 Code F | $89K14,511 at $6.10 | filing |
| 1 Mar 2026filed 3 Mar 2026 | INGN Inogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —28,334 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.